These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3308974)

  • 21. Development of mechanisms for drug excretion.
    Hook JB; Hewitt WR
    Am J Med; 1977 Apr; 62(4):497-506. PubMed ID: 851120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Age-related changes in drug disposition.
    Schmucker DL
    Pharmacol Rev; 1978 Dec; 30(4):445-56. PubMed ID: 392539
    [No Abstract]   [Full Text] [Related]  

  • 23. The application of basic principles of drug interaction to clinical practice.
    Robinson DS
    J Urol; 1975 Jan; 113(1):100-7. PubMed ID: 234541
    [No Abstract]   [Full Text] [Related]  

  • 24. [Renal excretion of water-soluble drugs].
    Ohsawa I; Tomino Y
    Nihon Jinzo Gakkai Shi; 2012; 54(7):977-80. PubMed ID: 23234207
    [No Abstract]   [Full Text] [Related]  

  • 25. Letter: Renal contribution to drug biotransformation.
    Kamath BL; Levy G
    J Pharm Sci; 1974 Aug; 63(8):1342-3. PubMed ID: 4852916
    [No Abstract]   [Full Text] [Related]  

  • 26. Urinary excretion of drugs in chronic renal impairment with respect to changes their tubular handling by residual nephrons.
    Schück O; Grafnetterová J; Nádvorniková H; Prát V
    Int J Clin Pharmacol Biopharm; 1976 Sep; 14(2):149-54. PubMed ID: 1036732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics and clearances related to renal processes.
    Garrett ER
    Int J Clin Pharmacol Biopharm; 1978 Apr; 16(4):155-72. PubMed ID: 649235
    [No Abstract]   [Full Text] [Related]  

  • 28. Finite dose pharmacokinetics of skin penetration.
    Cooper ER; Berner B
    J Pharm Sci; 1985 Oct; 74(10):1100-2. PubMed ID: 4078710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kinetic considerations relating to the accrual and elimination of drug metabolites.
    Cummings AJ; Martin BK; Park GS
    Br J Pharmacol Chemother; 1967 Feb; 29(2):136-49. PubMed ID: 6032052
    [No Abstract]   [Full Text] [Related]  

  • 30. [Pharmacokinetics of drug excretion in children].
    Prandota J
    Pol Tyg Lek; 1983 Dec 19-26; 38(51-52):1601-4. PubMed ID: 6679084
    [No Abstract]   [Full Text] [Related]  

  • 31. Therapeutic implications of renal anionic drug transporters.
    Masereeuw R; Russel FG
    Pharmacol Ther; 2010 May; 126(2):200-16. PubMed ID: 20227439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Drug pharmacokinetics and pharmacodynamics in children].
    Markova IV
    Farmakol Toksikol; 1982; 45(3):27-31. PubMed ID: 7095125
    [No Abstract]   [Full Text] [Related]  

  • 33. [Topics on transporter-mediated renal excretion and drug-drug interaction].
    Mizuuchi H
    Nihon Yakurigaku Zasshi; 2010 Jan; 135(1):30-3. PubMed ID: 20075568
    [No Abstract]   [Full Text] [Related]  

  • 34. Theoretical limits of changes in plasma protein binding on renal drug clearance.
    Cook JA; Smith DE
    J Pharm Sci; 1985 Jan; 74(1):108-9. PubMed ID: 3981408
    [No Abstract]   [Full Text] [Related]  

  • 35. Drug therapy in renal failure.
    Muther RS; Bennett WM
    Compr Ther; 1982 May; 8(5):44-57. PubMed ID: 7094560
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment of data from drug urinary excretion.
    Martin BK
    Nature; 1967 Apr; 214(5085):247-9. PubMed ID: 6034239
    [No Abstract]   [Full Text] [Related]  

  • 37. Relationship between the urinary excretion mechanisms of drugs and their physicochemical properties.
    Ito S; Ando H; Ose A; Kitamura Y; Ando T; Kusuhara H; Sugiyama Y
    J Pharm Sci; 2013 Sep; 102(9):3294-301. PubMed ID: 23712676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug urinary excretion data--some aspects concerning the interpretation.
    Martin BK
    Br J Pharmacol Chemother; 1967 Feb; 29(2):181-93. PubMed ID: 6032054
    [No Abstract]   [Full Text] [Related]  

  • 39. Consequences of renal insufficiency on the hepatic clearance of some drugs.
    Balant LP; Dayer P; Fabre J
    Int J Clin Pharmacol Res; 1983; 3(6):459-74. PubMed ID: 6147317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lag time before essentially constant urinary excretion rate is attained.
    Wagner JG; Northam JI
    J Pharm Sci; 1968 Jun; 57(6):994-9. PubMed ID: 5671348
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.